Skip to main content
Fig. 1 | BMC Medicine

Fig. 1

From: Recovery of serum testosterone levels is an accurate predictor of survival from COVID-19 in male patients

Fig. 1

Clinical biochemistry features of male (A, C) and female (B, D) COVID-19 patients, associated with outcomes. Clinical biochemistry values were determined for samples collected at patient admission. A, B Left panels: Principal component analysis (PCA) illustrating correlations between elevated levels of the indicated parameters and mild, moderate, severe survivor or severe deceased outcomes in male (A) or female (B) patients. Right panels: Heatmap of correlation coefficients between elevated levels of biochemical parameters and outcomes. Spearman multivariant correlation analyses were performed for all parameters vs. outcomes, the resulting coefficients normalized for each column (range, 0 to 1) and used to build heatmaps. C, D Values of relevant clinical biochemistry parameters assessed for admission samples and grouped by eventual outcome for male (C) and female (D) patients. Asterisks denote significance of pairwise comparisons between samples grouped by outcome: *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, and ****p ≤ 0.0001. Non-significant comparisons (p > 0.05) are not shown

Back to article page